Summary

U.S. Mechanical Ventilator Market Growth & Trends

The U.S. mechanical ventilators market size is estimated to reach USD 1.25 billion in 2030 and is expected to grow at a CAGR of 2.5% during the forecast period. The rising number of hospitalizations due to the coronavirus pandemic and the increased need for ventilation among patients in the U.S. contributed to the high demand for ventilators during the COVID-19 pandemic.

The rising prevalence of respiratory diseases has significantly impacted the market growth. The adoption of long-term Home Mechanical Ventilation (HMV) in case of chronic respiratory failure due to diseases, such as thoracic disease, Chronic Obstructive Pulmonary Disorder (COPD), and neuromuscular disease, is expected to increase over the forecast period.

According to a study by the World Health Organization (WHO), moderate to severe COPD affects around 65 million individuals worldwide, making it the third leading cause of death. These estimates are expected to rise over the years owing to the growing geriatric population, increasing exposure to tobacco smoke, and indoor as well as outdoor pollution. These factors are anticipated to boost the overall market growth.

An increase in the number of government initiatives aimed at providing safe, affordable, and quality healthcare is driving the adoption of these devices. For example, the American Society of Anesthesiologists provides guidelines for the management of difficult airways and the use of different devices at various stages of respiratory diseases.

Manufacturers have increased their production capacity to meet an exponential demand during the pandemic. For instance, Vyaire, an Illinois-based respiratory equipment manufacturer, ramped up its production capacity by 50%. To provide a safer environment for the healthcare workers, Medtronic upgraded its existing PB980 (deployed in ICUs), which will allow the control of ventilators remotely away from the isolation room. These types of initiatives positively impacted the ventilators market growth in the U.S.

However, a boost in ventilator production due to coronavirus wave is expected to be normalized by 2022 due to the decreased infection rates, dependency of patients on life support equipment, and development of an effective COVID-19 vaccine and therapeutics.

U.S. Mechanical Ventilator Market Report Highlights

• Based on product, the ventilators segment held the largest revenue share of over 83.94% in 2024 and is anticipated to grow at a fastest growth rate over the forecast year

• The growth of the U.S. mechanical ventilator market across various end use segments, including hospitals, home care, and others, is driven by several key factors

• The home care segment is witnessing significant growth, fueled by the growing number of government initiatives heading for curbing healthcare expenditures by promoting home healthcare to support market growth

• The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants

• The market is experiencing high innovation, driven by portability, automation, and advancements in AI integration

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Mechanical Ventilator: Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Mechanical Ventilator Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Ventilators
4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.4.2. Critical Care
4.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.4.3. Neonatal
4.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.4.4. Transport & Portable
4.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.4.5. Others
4.4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.5. Accessories
4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2. Breathing circuit sets
4.5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3. Flow sensors
4.5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.5.4. Endotracheal tubes
4.5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.5.5. Masks
4.5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.5.6. Others
4.5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. U.S. Mechanical Ventilator Market: End Use Estimates & Trend Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Hospital
5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.5. Home Care
5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Market Position Analysis
6.2. Company Categorization
6.3. Strategy Mapping
6.4. Company Profiles/Listing
6.4.1. Getinge
6.4.1.1. Overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. VYAIRE
6.4.2.1. Overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Medtronic
6.4.3.1. Overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Drägerwerk AG & Co. KGaA
6.4.4.1. Overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. GE Healthcare
6.4.5.1. Overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Koninklijke Philips N.V.
6.4.6.1. Overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Smiths Group plc
6.4.7.1. Overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Hamilton Medical
6.4.8.1. Overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. ResMed
6.4.9.1. Overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
6.4.10. Ventec Life Systems
6.4.10.1. Overview
6.4.10.2. Financial performance
6.4.10.3. Product benchmarking
6.4.10.4. Strategic initiatives